UMMC Navigation

Neuroscience

Main Content

Traumatic Cervical Spinal Cord Injury

Study title

Phase 2b/3 double blind randomized placebo controlled multicenter study to assess the efficacy and safety of VX-210 in subjects with acute traumatic cervical spinal cord injury

  • Principal Investigator: Dr. Louis Harkey

Purpose

This study will assess safety and efficacy of an experimental drug in patients with spinal cord injuries.

Who can participate  

Those eligible to participate in this study include:

  • Adults ges 18-75 with an acute spinal cord injury involving cervical spine

For more information

  • Heather Vaughn
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson MS 39216
    (601) 815-8724
  • IRB Number: 2017-0197